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Coronavirus disease 2019 (COVID-19) revealed many different faces, from severe to 
completely asymptomatic course. An increasing number of patients are starting to emerge 
with significant cardiovascular problems, including myocarditis, heart failure, severe 
arrhythmias, and thromboembolic complications. Accumulating data suggest that COVID-19 
is a systemic vascular endothelial dysfunction with different and unpredictable clinical 
manifestations, including pulmonary, neurological, cardiac, or thromboembolic problems. Of 
note, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters target cells via 
angiotensin-converting enzyme 2 (ACE2) receptors, which are widely expressed on the 
endothelial cells in several organs, including the heart and lungs [1]. Indeed, an increasing 
amount of evidence indicates that SARS-CoV-2 affects endothelial function via inflammation 
of endothelial cells (endotheliitis), causing microvascular disturbances and microthrombosis 
in different vascular beds, leading to COVID-19-related acute and long-term complications 
[2]. 
More precisely, SARS-CoV-2 affects vascular endothelium by multiple mechanisms, 
including a cytokine storm. Interestingly, exocytosis of granules from endothelial cells 
induces platelet aggregation and leukocyte influx into the vessel wall, which causes 
inflammation, microthrombosis, and capillary obstruction [3]. The blood flow disturbances in 
capillaries due to endotheliitis or accumulation of leukocytes shortens the time of blood flow 
resulting in reduced oxygen exchange between blood and tissue. Hypoxia of endothelial cells 
via transit-time effects leads to the further secretion of inflammatory cytokines, which 
provides another brick for endothelial damage [4].
Microcirculation plays a pivotal role in tissue oxygenation and nutrient supply. The 
decrease in oxygen delivery during endotheliitis may induce tissue hypoxia and inhibits 
metabolism. Accumulating evidence suggests that COVID-19-induced endotheliitis is 
predominately a systemic small-vessel vasculitis not involving the large arteries such as the 
main coronaries [5]. Owing to its accessibility, a peripheral microvascular function has been 
considered an indicator of general microvascular function [6]. Several methods are available 
to study peripheral microcirculation and attempt to quantify perfusion or oxygenation. 
However, we can currently assess the variation in tissue biochemistry in vivo using the 
measurements of a nicotinamide adenine dinucleotide (NADH) fluorescence signal intensity 
[7].
The newly developed flow-mediated skin fluorescence (FMSF) is a non-invasive 
optical technique to study microcirculation and metabolic regulation based on cutaneous 
NADH fluorescence intensity registration. Excitation of the forearm with ultraviolet (UV) 
light at 340 nm results in the emission of a NADH fluorescence signal from human epidermal 
cells. Indeed, the epidermis is particularly sensitive to hypoxia. The level of NADH 
fluorescence corresponds to the balance of mitochondrial oxidation-reduction processes 
occurring in the tissue, reflected by the balance between the oxidized form of the coenzyme 
(NAD+) and its reduced form (NADH). The emitted fluorescence light of NADH at 460 nm is 
detected by the receiver diode and corresponds to the activity of microcirculation [7]. Of note,
the FMSF device exhibits excellent reproducibility and reasonable agreement for repeated 
measurements [8].
To assess microvascular reactivity and endothelial function, the FMSF device 
measures the changes in the intensity of NADH fluorescence in the epidermis over time in 
response to brachial artery occlusion. Technically, FMSF registers two principal parameters: 
ischemic response (IR) and hyperemic response (HR). The parameter IRmax is defined as the 
ratio (in %) of relative to maximal baseline increase in NADH fluorescence intensity observed
over occlusion, whereas IRindex is calculated as the area under the curve (AUC) of IR in 
relation to the baseline. Subsequently, the parameter HRmax is expressed (in %) as the relative 
to maximal baseline decrease in NADH fluorescence intensity during the reperfusion phase, 
while HRindex is defined as the AUC of the IR. When HR reflects microvascular reactivity and 
endothelial function, the IR may mirror tissue sensitivity to hypoxia [9].
Additionally, the FMSF device registers oscillations in the microcirculation, known as 
flowmotion, specifically present in skin microvascular blood flow. We distinguish endothelial,
neurogenic, myogenic, respiratory, and cardiac oscillations based on the frequency analysis. 
There is compelling evidence that impaired flowmotion may be a symptom of various 
disorders, including diabetes, a broad spectrum of cardiovascular diseases, and autoimmune 
and infectious diseases such a COVID-19 [10].
The direct measurement of oscillations during the reperfusion stage enables us to 
determine the hypoxia sensitivity (HS) parameter, which covers the intensity of flowmotion 
related to myogenic oscillations. Of note, myogenic oscillations are mainly stimulated on the 
reperfusion line following transient ischemia. Therefore, the HS parameter seems to be 
particularly significant to determine the microcirculatory response to hypoxia. Interestingly, 
low HS values were related to a more severe course of COVID-19. Further, it was recently 
suggested that the microcirculatory response to hypoxia expressed as the HS parameter could 
be a prognostic factor in COVID-19 [10].
Accumulating evidence suggests that we should consider COVID-19 as a systemic 
microvascular endothelial disease with different clinical manifestations from severe and acute 
to completely asymptomatic course [1, 2]. Therefore, non-invasive, sensitive, and reliable 
methods for microvascular endothelial function clinical monitoring are strongly needed.
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Figure 1. Exemplary image of nicotinamide adenine dinucleotide (NADH) fluorescence trace 
in response to blockage and release of blood flow in the brachial artery. The ischemic 
response (IRmax and IRindex) is relative to the baseline increase in NADH fluorescence intensity 
observed during occlusion, and the hyperemic response (HRmax and HRindex) is relative to 
baseline decrease in NADH fluorescence intensity over the reperfusion stage.
Figure 2. A. Typical image of nicotinamide adenine dinucleotide (NADH) fluorescence trace 
in a 30-year-old healthy subject with very high value of hypoxia sensitivity (HS) parameter as
well as very dynamic ischemic and hyperemic responses; B. Image of significant 
microvascular disturbances in NADH fluorescence trace in 30-year-old post-COVID patient 
with very low value of HS parameter as well as poor ischemic response (IRmax and IRindex).
